Kucera closes on $1.9M

BT Catalyst,  Sept, 2002  

• E-mail
• Print
• Link

Kucera Pharmaceuticals of Winston-Salem recently closed on $1.9 million in Series A financing, which will be used by the company for the development of phospholipid drug delivery systems.

Academy Venture Fund of Winston-Salem was the lead investor. Piedmont Angel Network of Greensboro and other private investors also contributed to the round.

Kucera -- a spin off of Wake Forest University School of Medicine and the University of North Carolina at Chapel Hill -- will use the funds to develop and test compounds expected to increase the effectiveness of existing drugs and improve their toxicity.

For more information visit the company's Web site at www.kucerapharma.com.

COPYRIGHT 2002 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning